Forman Mark S 4
4 · Passage BIO, Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Forman Mark S
Chief Medical Officer
Transactions
- Award
Employee Stock Options (right to buy)
2022-04-18+136,000→ 136,000 totalExercise: $2.61Exp: 2032-04-17→ Common Stock (136,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on April 18, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.